trial · primary record
Ivonescimab Combined With Chemotherapy
Malignant Pleural Mesothelioma, Advanced
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 78 |
| Primary completion | 2028-11-30 |
| Primary endpoint | Dose-Limiting Toxicities in Phase 1b |
| Registry ID | NCT07885319 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:01.847Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07885319
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.